Latest Cutaneous lupus erythematosus Stories
LONDON, May 22, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
HERZLIYA, Israel, May 19, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd.
SHENZHEN, China, May 13, 2014 /PRNewswire/ -- Chinese researchers have recently published new findings in Arthritis
NEW YORK, May 10, 2014 /PRNewswire/ -- S.L.E. Lupus Foundation's Young Leaders took Lupus Research to the Power of 10 in recognition of World Lupus Awareness Day May 10.
- Significant clinical response to Acthar was observed in patients experiencing active disease while on conventional SLE maintenance therapies - ANAHEIM, Calif., May 5, 2014 /PRNewswire/ --
May Lupus Research Awareness Month Campaign Aims to Enlist 1 Million To Work For a World Without Lupus NEW YORK, May 1, 2014 /PRNewswire/ -- To recognize World Lupus Day, May 10, the
According to a new report from BCC Research, the global market for drugs to treat systemic lupus erythematosus (SLE), is expected to grow to $2.6 billion by 2018, with a five-year compound annual
Project Runway's Tim Gunn Joins 400 NYC Leaders at S.L.E.
Lupus Science & Medicine is launched to provide the latest lupus research and stimulate collaborative efforts to improving the lives of all people affected by lupus WASHINGTON, April 3, 2014
HERZLIYA, Israel, March 25, 2014 /PRNewswire/ -- XTL Biopharmaceuticals Ltd. (NASDAQ: XTLB, TASE: XTL) ("XTL" or the "Company"),
- An uxorious, effeminate, or spiritless man.
- A timorous, cowardly fellow.